Myoglobin has a relatively high molecular weight of 17,000 Da and is poorly
cleared by dialysis (diffusion). However, elimination of myoglobin might b
e enhanced by an epuration modality based on convection for solute clearanc
es. We present a single case of myoglobin-induced renal failure (peak creat
ine kinase level: 313,500 IU/1) treated by continuous venovenous hemofiltra
tion (CVVH). Our purpose was to evaluate the efficiency of such a modality
using an ultrafiltration rate of 2 to 3 l/h for myoglobin removal and clear
ance. The hemofilter was a 0.9 m(2) polyacrylonitrile (AN69) membrane Multi
flow-100 (Hospal-Gambro, St-Leonard, Canada) and the blood now rate was mai
ntained at 150 ml/min by an AK-10 pump (Hospal-Gambro, St-Leonard, Canada).
The ultrafiltration bag was placed 60 cm below the hemofilter and was free
of pump control or suction device. Serum myoglobin concentration was 92,00
0 mu g/l at CVVH initiation and dropped to 28,600 mu g/l after 18 h of the
continuous modality. The mean sieving coefficient for myoglobin was 0.6 dur
ing the first 9 h of therapy and this decreased to 0.4 during the following
7 h. Mean clearance of myoglobin was 22 ml/min, decreasing to 14 ml/min du
ring corresponding periods, while the mean ultrafiltration rates were relat
ively stable at 2,153 +/- 148 ml/h and 2,074 +/- 85 ml/h, respectively. In
contrast to myoglobin, the sieving coefficeint for urea, creatinine, and ph
osphorus remained stable at 1.0 during the first 16 h of CVVH. More than 70
0 mg of myoglobin were removed by CVVH during the entire treatment. In conc
lusion, considerable amounts of myoglobin can be removed by an extracorpore
al modality allowing important convective fluxes and middle molecule cleara
nces, such as CVVH at a rate of 2 to 3 l/h using an AN69 hemofilter. If myo
globin clearance had been maintained at 22 ml/min, 32 1 of serum would have
been cleared per day. However, the sieving coefficient of myoglobin decrea
sed over time, probably as a consequence of protein coating and/ or blood c
lotting of the hemofilter. Whereas myoglobin can be removed by CVVH, it rem
ains unknown at this point if such a modality, applied early, can alter or
shorten the course of myoglobinuric acute renal failure.